PaaSicats: Powerful catalysts for asymmetric epoxidation of enones. Novel syntheses of α-arylpropanoic acids including (S)-fenoprofen

Tetrahedron Letters

Volumn 40, Issue 29, 1999, Pages 5421-5424

  Carde, Lydia ^a   Davies, Huw ^b   Geller, Thomas P ^a   Roberts, Stanley M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Aluminium and compounds; Asymmetric reactions; Epoxidation; Pharmacologically active compounds

Indexed keywords

ACETONE; ACETONE DERIVATIVE; ALUMINUM DERIVATIVE; DICHLOROMETHANE; EPOXIDE; FENOPROFEN; PHENYLPROPIONIC ACID DERIVATIVE; POLYAMINOACID; POLYLEUCINE; PROPIONIC ACID DERIVATIVE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; EPOXIDATION; STEREOCHEMISTRY; TRIMETHYLALUMINUM;

EID: 0033575456     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)01022-9     Document Type: Article

References (20)

1. Banfi, S.; Colonna, S.; Molinari, H.; Juliá, S.; Guixer, J. Tetrahedron, 1984, 40, 5207.
2. Adger, B. M.; Barkley, J. V.; Bergeron, S.; Cappi, M. W.; Flowerdew, B. E.; Jackson, M. P.; McCague, R.; Nugent, T. C.; Roberts, S. M. J. Chem. Soc., Perkin Trans. 1, 1997, 3501.
3. Allen, J. V.; Roberts, S. M.; Williamson, N. M. Adv. Biochem. Biotech., 1998, 63, 125; Ebrahim, S.; Wills, M. Tetrahedron: Asymmetry, 1997, 8, 3163.
4. Allen, J. V.; Roberts, S. M.; Williamson, N. M. Adv. Biochem. Biotech., 1998, 63, 125; Ebrahim, S.; Wills, M. Tetrahedron: Asymmetry, 1997, 8, 3163.
5. Geller, T. P.; Roberts, S. M. J. Chem. Soc., Perkin Trans. 1, 1999, in press.
6. Zhong, Y.-L.; Shing, T. K. M. J. Org. Chem., 1997, 62, 2622.
7. Senanayake, C. H.; Bill, T. J.; Larsen, R. D.; Leazer, J.; Reider, P. J. Tetrahedron Lett., 1992, 33 5901.
8. Nakagaki, R.; Takahira, O.; Yamaoka, M.; Kashima, N. Bull. Chem. Soc. Jpn., 1995, 68, 2803.
9. Suzuki, T.; Saimoto, H.; Tomioka, H.; Oshima, K.; Nozaki, H. Tetrahedron Lett., 1982, 23, 3597.
10. Fukumasa, N.; Furakashi, K.; Umezawa, J.; Takahashi, O.; Hirai, T. Tetrahedron Lett., 1991, 32, 1059.
11. The (S)-enantiomer is the active anti-inflammatory agent: Hutt, A. J.; Caldwell, J. Clin. Pharmacokin., 1984, 9, 371; Williams, K. M.; Day, R. O.; Breit, S. N. Biochemical actions and clinical pharmacology of anti-inflammatory drugs. In Advances in Drug Research; Academic Press, 1993; Vol. 24; 121.; Rieu, J.-P.; Boucherle, A.; Cousse, H.; Mouzin, G. Tetrahedron, 1986, 42, 4095.
12. The (S)-enantiomer is the active anti-inflammatory agent: Hutt, A. J.; Caldwell, J. Clin. Pharmacokin.,1984, 9, 371; Williams, K. M.; Day, R. O.; Breit, S. N. Biochemical actions and clinical pharmacology of anti-inflammatory drugs. In Advances in Drug Research; Academic Press, 1993; Vol. 24; 121.; Rieu, J.-P.; Boucherle, A.; Cousse, H.; Mouzin, G. Tetrahedron, 1986, 42, 4095.
13. The (S)-enantiomer is the active anti-inflammatory agent: Hutt, A. J.; Caldwell, J. Clin. Pharmacokin.,1984, 9, 371; Williams, K. M.; Day, R. O.; Breit, S. N. Biochemical actions and clinical pharmacology of anti-inflammatory drugs. In Advances in Drug Research; Academic Press, 1993; Vol. 24; 121.; Rieu, J.-P.; Boucherle, A.; Cousse, H.; Mouzin, G. Tetrahedron, 1986, 42, 4095.
14. Warneck, J. B. H.; Wisdom, R. A. European Patent EP 0687305 B1.
15. Zhu, X.; Lin, B.; Epperlein, U.; Koppenhoefer, B. Chirality, 1999, 11, 56; Ducret, A.; Trani, M.; Lortie, R. Enzyme Microb. Technol., 1998, 22, 212.
16. Zhu, X.; Lin, B.; Epperlein, U.; Koppenhoefer, B. Chirality, 1999, 11, 56; Ducret, A.; Trani, M.; Lortie, R. Enzyme Microb. Technol., 1998, 22, 212.
17. For a new method involving asymmetric hydroboration/carbonylation see Chen, A. C.; Ren, L.; Crudden, C. M. Chem. Commun., 1999, 611; see also Xie, B.-H.; Xia, C.-G.; Lu, S.-J.; Chen, K.-J.; Kou, Y.; Yin, Y.-Q. Tetrahedron Lett., 1998, 39, 7365; Chang, C.-S.; Tsai, S.-W.; Lin, C.-N. Tetrahedron: Asymmetry, 1998, 9, 2799 and references cited therein.
18. For a new method involving asymmetric hydroboration/carbonylation see Chen, A. C.; Ren, L.; Crudden, C. M. Chem. Commun., 1999, 611; see also Xie, B.-H.; Xia, C.-G.; Lu, S.-J.; Chen, K.-J.; Kou, Y.; Yin, Y.-Q. Tetrahedron Lett., 1998, 39, 7365; Chang, C.-S.; Tsai, S.-W.; Lin, C.-N. Tetrahedron: Asymmetry, 1998, 9, 2799 and references cited therein.
19. For a new method involving asymmetric hydroboration/carbonylation see Chen, A. C.; Ren, L.; Crudden, C. M. Chem. Commun., 1999, 611; see also Xie, B.-H.; Xia, C.-G.; Lu, S.-J.; Chen, K.-J.; Kou, Y.; Yin, Y.-Q. Tetrahedron Lett., 1998, 39, 7365; Chang, C.-S.; Tsai, S.-W.; Lin, C.-N. Tetrahedron: Asymmetry, 1998, 9, 2799 and references cited therein.
20. W. S. Marshall (Eli Lilly and Co.) Patent FR 2015728.